Pituitary Adenoma Imaging as a Key Determinant of Acromegaly Diagnosis and Outcomes

Overview

Acromegaly is a rare hormonal disorder most often caused by a growth hormone–secreting pituitary adenoma, also called a somatotroph adenoma. In more than 95% of cases, the tumor arises in the pituitary gland at the base of the brain. Over time, excess growth hormone leads to elevated insulin-like growth factor 1 (IGF-1), which drives the characteristic features of acromegaly, including enlarged hands and feet, facial changes, joint pain, sweating, sleep apnea, and metabolic complications such as diabetes and hypertension.

Although the diagnosis of acromegaly is confirmed through biochemical testing, imaging is essential for locating the tumor, estimating its size and extent, and planning treatment. High-quality pituitary imaging has become one of the most important factors in determining both the accuracy of diagnosis and the likelihood of long-term disease control.